These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 4232163)

  • 1. Fibrinolytic system in hypotensive patients; with a special reference to the effect of epsilon-amino caproic acid (EACA).
    Gabryelewicz A; Niewiarowski S; Prokopowicz J; Worowski K
    Thromb Diath Haemorrh; 1967 Dec; 18(3-4):433-8. PubMed ID: 4232163
    [No Abstract]   [Full Text] [Related]  

  • 2. The in-vivo-effect of E-aminocaproic acid (EACA) on human plasma fibrinolytic system.
    Niewiarowski S; Wolosowicz N
    Thromb Diath Haemorrh; 1966 May; 15(3):491-500. PubMed ID: 4865186
    [No Abstract]   [Full Text] [Related]  

  • 3. Substrate composition and the effect of epsilon-aminocaproic acid on tissue plasminogen activator and urokinase-induced fibrinolysis.
    Thorsen S; Astrup T
    Thromb Diath Haemorrh; 1974 Dec; 32(2-3):306-24. PubMed ID: 4281113
    [No Abstract]   [Full Text] [Related]  

  • 4. Synergistic antifibrinolytic action of the potato protease inhibitor and epsilon-aminocaproic acid.
    Worowski K
    Acta Biol Acad Sci Hung; 1976; 27(2-3):125-8. PubMed ID: 140568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro inhibition of streptokinase-induced proteolysis by Trasylol and by epsilon amino caproic acid (EACA).
    Godal HC; Theodor I
    Scand J Clin Lab Invest; 1965; 17():Suppl 84:199+. PubMed ID: 5295419
    [No Abstract]   [Full Text] [Related]  

  • 6. Reversible and irreversible alterations of human plasminogen indicated by changes in susceptibility to plasminogen activators and in response to epsilon-aminocaproic acid.
    Thorsen S; Kok P; Astrup T
    Thromb Diath Haemorrh; 1974 Dec; 32(2-3):325-40. PubMed ID: 4450189
    [No Abstract]   [Full Text] [Related]  

  • 7. Synthesis and activity of N alpha-(epsilon-aminocaproyl)-alanines and N epsilon-(epsilon-aminocaproyl)-caproic acid.
    Midura-Nowaczek K; Bruzgo I; Popławski J; Roszkowska-Jakimiec W; Worowski K
    Acta Pol Pharm; 1995; 52(6):505-7. PubMed ID: 8960269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The behavior of plasmatic fibrinogenolytic activity after activation with streptokinase and urokinase in presence of epsilon amino-caproic acid and of the parotid inhibitor of trypsin].
    Ferrauto A; Cristaldi R; Terranova R; Giuffrida G
    Boll Soc Ital Biol Sper; 1965 Dec; 41(24):1486-7. PubMed ID: 5298373
    [No Abstract]   [Full Text] [Related]  

  • 9. In vivo studies on the mechanism of the antifibrinolytic action of E-aminocaproic acid (EACA).
    Lukasiewicz H; Niewiarowski S
    Thromb Diath Haemorrh; 1968 Jul; 19(3):584-92. PubMed ID: 4236825
    [No Abstract]   [Full Text] [Related]  

  • 10. The biochemistry of the fibrinolytic enzyme system in man.
    Rickli EE
    Angiologica; 1968; 5(2):66-79. PubMed ID: 4232516
    [No Abstract]   [Full Text] [Related]  

  • 11. Enhancement of fibrinolysis in rabbits exposed to low and moderate levels of carbon monoxide inhibited by epsilon amino caproic acid.
    Kalmaz EV; Canter LW; Coleman RL; Hampton JW
    Thromb Haemost; 1978 Feb; 39(1):109-21. PubMed ID: 580486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of epsilon-amino-caproic acid, acetyl-epsilon-amino-caproic acid and trasylol on allergic reactions induced by dinitrochlorobenzen in guinea pigs.
    Onisk Z; Tchórzewski H
    Pol Med J; 1968; 7(1):190-5. PubMed ID: 5300915
    [No Abstract]   [Full Text] [Related]  

  • 13. [On the effect of a new synthetic inhibitor of the fibrinolytic system].
    Fischer M; Pavlu C
    Arzneimittelforschung; 1966 May; 16(5):671-3. PubMed ID: 6014440
    [No Abstract]   [Full Text] [Related]  

  • 14. [The effect of epsilon-aminocaproic acid administered to parturient women on the blood coagulation system of the newborn].
    Budyka LA
    Vopr Okhr Materin Det; 1968 Jan; 13(1):31-4. PubMed ID: 5719518
    [No Abstract]   [Full Text] [Related]  

  • 15. Measurement of fibrinolytic activity after epsilon-aminocaproic acid administration in rats (Rattus norvegicus).
    Gogjian MA; Barry KJ; Stein BM
    Lab Anim Sci; 1981 Dec; 31(6):710-1. PubMed ID: 7343767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Fibrinolytic activity of the wall of veins].
    Büttner D; Schmidt FC
    Vasa; 1972; 1(1):24-8. PubMed ID: 4260129
    [No Abstract]   [Full Text] [Related]  

  • 17. [The influence of fibrinolysis inhibitors on the effect of bioactive substances on the guinea pig ileum. Studies on the problem of the effect of epsilon-aminocaproic acid, acetyl-epsilon-aminocaproic acid and p-aminomethylbenzoic acid].
    Doleschel W; Auerswald W
    Wien Med Wochenschr; 1966 Feb; 116(7):130-4. PubMed ID: 4293171
    [No Abstract]   [Full Text] [Related]  

  • 18. [Activation and inhibition of buffy crust fibrinolysis in vitro].
    Harms D
    Gegenbaurs Morphol Jahrb; 1968; 111(3):488-92. PubMed ID: 4232858
    [No Abstract]   [Full Text] [Related]  

  • 19. Differentiation between plasminogen activators by means of epsilon-aminocaproic acid.
    Kok P; Astrup T
    Thromb Diath Haemorrh; 1972 Feb; 27(1):77-87. PubMed ID: 4260740
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of epsilon-aminocapronic acid on fibrinolysis of euglobulins activated by endogenous activators of plasminogen].
    Chmielewski J
    Pol Tyg Lek; 1965 Jul; 20(27):990-1. PubMed ID: 5840160
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.